Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;24(6):e090224226818.
doi: 10.2174/0118715265209731240129042916.

Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran

Affiliations

Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran

Mansour Babaei et al. Infect Disord Drug Targets. 2024.

Abstract

Background: The spectrum of the clinical features of coronavirus disease 2019 (COVID-19) spans from asymptomatic or mild disease to severe respiratory failure, while different factors are related to its mortality rate. This research aimed to determine the clinical and laboratory characteristics and the associated factors of mortality in patients with COVID-19.

Materials and methods: Data were collected from hospitalized patients (May to June 2020), and COVID-19 was confirmed in patients by real-time polymerase chain reaction (PCR). The patient group was classified into survivor and deceased groups. The chi-square and the independent t-test with Statistical Package for the Social Sciences (SPSS) software program, version 18, were used for analysis.

Results: Mean age, hemoglobin, serum C-reactive protein (CRP), alkaline phosphatase (ALP), white blood cells, and level of procalcitonin in non-survivors were significantly higher than in survivors. Serum tumour necrosis factor-alpha (TNF-a) had a significant relationship with Ddimer (p = 0.0006). The risk of mortality in patients with serum CRP ≥ 100 mg/dl was significantly higher than those with CRP < 100 mg/dl (odds ratio (OR) = 4.8 (95% CI, 1.33-12.44, p = 0.01).

Conclusion: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.

Keywords: Clinical characteristics; c-reactive protein; coronavirus disease 2019.; infection; laboratory characteristics; mortality.

PubMed Disclaimer

Similar articles

References

    1. Xiong S.; Liu L.; Lin F.; Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: A single-centered, retrospective, observational study. BMC Infect Dis 2020,20(1),787 - DOI - PubMed
    1. Perincek G.; Avci S.; A case series of patients with COVID-19 infection admitted to a secondary care center in Turkey. Front Emerg Med 2020,4(2s),e49
    1. Mostafa A.; Kandil S.; El-Sayed M.H.; Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers. Int J Epidemiol 2021,50(1),50-61 - DOI - PubMed
    1. Kochhar A.; Pande D.; Saini S.; Ganapathy U.; Gogia A.; An update on initial epidemiological profile, clinical course, and outcome of COVID-19 patients at a tertiary care center in India. Indian J Palliat Care 2020,26(5)(Suppl. 1),36 - DOI - PubMed
    1. Ozma M.A.; Maroufi P.; Khodadadi E.; Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med 2020,28(2),153-165 - PubMed